Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors

BACKGROUND: RCSD1 is a cytoskeletal regulator that has been confirmed to undergo genetic mutations in hematological tumors, but the mechanisms of RCSD1 in pan-cancer and its impact on patient prognosis have not been studied. METHODS: Using TCGA, GEPIA, UALCAN, Kaplan-Meier plotters, Linkedomics, Str...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Han, Yin, Hong, Feng, Yan, Tang, Huaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606721/
https://www.ncbi.nlm.nih.gov/pubmed/36311703
http://dx.doi.org/10.3389/fimmu.2022.1008778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606721/
https://www.ncbi.nlm.nih.gov/pubmed/36311703
http://dx.doi.org/10.3389/fimmu.2022.1008778

Ejemplares similares